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Diverse coronaviruses have been identiﬁ  ed in bats from 
several continents but not from Africa. We identiﬁ  ed group 
1 and 2 coronaviruses in bats in Kenya, including SARS-re-
lated coronaviruses. The sequence diversity suggests that 
bats are well-established reservoirs for and likely sources of 
coronaviruses for many species, including humans.
T
he 2003 outbreak of severe acute respiratory syndrome 
(SARS) generated renewed interest in coronaviruses 
(CoV) and the source for the SARS CoV that caused the 
outbreak in humans (1). Serologic studies demonstrated that 
the virus had not previously circulated in human popula-
tions to any large extent and suggested a source of zoonotic 
origin (2–4). A likely natural viral reservoir for the virus 
was not identiﬁ  ed until horseshoe bats (Rhinolophus spp.) 
in several regions in the People’s Republic of China were 
demonstrated to harbor SARS-like CoVs (5). Subsequent-
ly, a number of other SARS-like CoVs, as well as CoVs 
from antigenic groups I and II, were identiﬁ  ed from bats 
in Asia, Europe, and North America, and coronavirus anti-
bodies were detected in African bat species (6–11). It is not 
surprising that a growing number of CoVs have been de-
tected in bats. To date, >60 viral species have been detected 
in bats because their biodiversity (second only to rodents), 
high population densities, wide distribution, and ability 
to ﬂ  y over long distances allow them to harbor and eas-
ily spread multiple infectious agents. Bats have long been 
known as natural hosts for lyssaviruses and more recently 
have been recognized as potential reservoirs for emerging 
human pathogens, including Ebola, Marburg, Nipah, and 
Hendra viruses in addition to SARS-CoV (12,13). 
The Study
Given the association of bats with emerging infectious 
diseases, ﬁ  eld surveys were performed during July–August 
2006 in the southern portion of Kenya (Figure 1). The se-
lection of sites was based on preliminary data regarding 
bat roost locations and observations of bats in the ﬁ  eld dur-
ing the survey. Attempts were made to collect specimens 
from 10–20 animals of each species present in each loca-
tion. Bats were captured manually and by using mist nets 
and hand nets; adults and subadults of both sexes were cap-
tured. Each bat was measured, sexed, and identiﬁ  ed to the 
genus or species level when possible. Blood samples and 
oral and fecal swabs were collected; the animals were then 
euthanized in compliance with ﬁ  eld protocol. Blood, fecal 
swabs, and selected tissue samples were transported on dry 
ice from the ﬁ  eld and stored at –80°C.
Fecal swabs (n = 221; Table) were screened for the 
presence of CoV RNA using 2 semi-nested reverse tran-
scription-PCR (RT-PCR) assays. For the pan-coronavirus 
RT-PCR, conserved primers were designed from highly 
conserved regions of the RNA-dependent RNA poly-
merase (RdRp) gene 1b based on available CoV sequenc-
es (1st and 2nd round forward 5′-ATGGGITGGGAY 
TATCCWAARTGTG-3′; 1st round reverse 5′-AATTAT 
ARCAIACAACISYRTCRTCA-3′; 2nd round reverse 5′-
CTAGTICCACCIGGYTTWANRTA-3′). For the pan–bat 
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Figure 1. Map of Kenya showing the locations of 17 bat collection 
sites.Coronaviruses in Bats from Kenya
coronavirus RT-PCR, conserved primers were designed 
from the same highly conserved regions based on avail-
able bat CoV sequences and presumed to be more spe-
ciﬁ  c to bat coronaviruses (1st and 2nd round forward 5′-
ATGGGITGGGAYTATCCWAARTGTG-3′; 1st round 
reverse 5′-TATTATARCAIACIACRCCATCRTC-3′; 2nd 
round reverse 5′-CTGGTICCACCI GGYTTNACRTA-3′). 
Total nucleic acids were extracted from 200 μL of a phos-
phate buffered saline suspension of each swab by using the 
QIAamp Mini Viral Elute kit (QIAGEN, Santa Clarita, CA, 
USA), according to the manufacturer’s instructions. The 
seminested RT-PCR was performed by using the SuperScript 
III One-Step RT-PCR kit and Platinum Tag Kit (Invitrogen, 
San Diego, CA, USA). The positive PCR products were pu-
riﬁ  ed by gel extraction by using the QIAquick Gel Extraction 
kit (QIAGEN) according to the manufacturer’s instructions; 
they were then sequenced on an ABI Prism 3130 automated 
sequencer (Applied Biosystems, Foster City, CA, USA), ac-
cording to the manufacturer’s instructions. 
Of 221 bat fecal swabs examined, 41 (19%) were 
positive by at least 1 of the 2 seminested RT-PCR assays 
(Table). One specimen had 2 distinct CoV sequences, each 
ampliﬁ  ed by 1 of the 2 PCR assays, giving a total of 42 dis-
tinct CoV sequences. To characterize the overall diversity of 
CoV sequences, in this study a phylogenetic tree (Figure 2) 
of the 121-bp fragment of RdRp was generated from 39 
coronaviruses from bats in Kenya and 47 selected human 
and animal coronaviruses from the National Center for 
Biotechnology Information database based on the Bayesian 
Monte Carlo Markov Chain method (14). Three of the 42 
sequences were not of sufﬁ  ciently high quality to include 
in this tree. Some nodes had low Bayesian posterior prob-
abilities (Figure 2). Longer sequences from these viruses 
are needed to reﬁ  ne their phylogenetic relationships. 
Among the 39 sequences in the tree, 23 belonged to 
previously deﬁ  ned group 1 and were mapped into 5 dif-
ferent sequence clusters. The 121-bp sequences in these 
5 clusters had an average nucleic acid (NA) sequence 
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Table. Results of detection of CoV RNA in fecal swabs of bats from Kenya* 
Bat species  Geographic location  
PCR results, no. 
positive/no. tested  Clusters
Cardioderma cor 15 0/10
12 1/3 BtCoVA970-like
Chaerophon sp. 6 1/14 BtHKU7-like
17 6/19 BtHKU7-like, BtKY18-like, SARSCoV-like 
30 / 5
Chaerophon pumilus 3 2/3 HCoV229E-like
11 0/4
Coleura afra 11 0/1
14 0/1
Eidolon helvum 4 6/10 BtKY18-like 
Epomophorus wahlbergi 90 / 3
Hipposideros commersoni 14 1/10 BtHKU9-like
Hipposideros ruber 20 / 4
50 / 2
Lissonycteris angolensis 50 / 1 0
Miniopterus africanus 10 1/8 BtCoV1A-like
Miniopterus inflatus 5 7/12 BtCoV1A-like, BtHKU8-like
Miniopterus minor 13 1/16 BtCoV1A-like
Miniopterus natalensis 1 1/7 BtCoV1A-like
Neoromicia tenuipinnis 60 / 4
Otomops martinsseni 7 2/19 BtHKU7-like
Pipistrellus sp. 80 / 1
Rhinolophus hildebrandtii 10 0/4
Rhinolophus sp. 14 0/1
13 0/1
80 / 5
Rousettus aegyptiacus 1 2/10 BtKY18-like 
2 2/9 BtCoVA970-like, BtHKU9-like
16 6/9 BtCoVA970-like, BtHKU9-like
13 2/11 BtHKU9-like
Taphozous hildegardeae 14 0/3
Taphozous sp. 11 0/2
Total 41/221 (19%) 
*CoV, coronavirus; SARS, severe acute respiratory syndrome. identity of 88%, 85%, 81%, 77%, and 80% when com-
pared with the next closest previously characterized CoVs 
(i.e., BtCoV1A, BtHKU8, BtHKU7, HCoV229E, and 
BtCoVA970, respectively). The remaining 16 sequences 
would likely be placed into group 2. Two sequences from 
Chaerophon spp. bats (location 17) were closely related to 
a SARS-like CoV cluster, including 1 sequence shown in 
Figure 2 (BtKY15) and another (BtKY16) that was 1 of 
the 3 low-quality sequences excluded from the tree. These 
2 NA sequences show ≈89% identity with the nearest pre-
viously characterized bat: SARS-like CoV, BtCoVRF1, 
shows ≈80% NA sequence identity to SARS CoV (Urbani 
strain) and ≈63% NA sequence identity to the human group 
2 CoV HCoVOC43. The 15 remaining NA sequences were 
grouped into 2 clusters. One cluster contains the recently 
described BtHKU9 with >95% NA sequence identity, and 
the other cluster (BtKY18-like cluster) contains no other 
previously known CoVs, with <75% NA sequence identity 
to BtHKU9. 
The pattern of CoV detections by bat species and lo-
cation demonstrates several features concerning coronavi-
ruses in bats. A given bat species in the same location can 
harbor several distinct CoVs as noted for Chaerophon spp. 
(location 17), Miniopterus inﬂ  atus (location 5), and Rouset-
tus aegyptiacus (location 2 and 16); similar CoVs can also 
been seen in the same type of bat in different locations, 
as noted for BtCoV1A-like cluster CoVs being detected in 
Miniopterus spp. bats of 4 species from different locations. 
One M. inﬂ  atus bat from location 5 harbored 2 different, 
but closely related, CoVs, 1 (BtCoV 36) from the BtCo-
V1A-like cluster and 1 (BtCoV 35) from the BtHKU8-like 
cluster (Figure 2). CoVs of these 2 closely related clusters 
were detected in Miniopterus spp. bats, but not detected in 
other bat genera, including those that shared roosts with 
Miniopterus spp. bats. This ﬁ  nding is consistent with stud-
ies from China in which BtCoV1A-like and BtHKU8-like 
CoVs were frequently identiﬁ  ed but only in Miniopterus 
spp. bats (15). This may suggest that viruses of the BtCo-
V1A-like cluster and the BtHKU8-like cluster are speciﬁ  -
cally adapted to Miniopterus spp. bats and not easily trans-
mitted to other bat species. 
In contrast, other genetically similar CoVs were detect-
ed in several different bat species. For example, CoVs from 
th BtHKU7-like cluster were detected in both Chaerophon 
spp. and Otomops martinsseni bats; CoVs from the BtCo-
VA970-like cluster were detected in Cardioderma cor and 
Rousettus aegyptiacus bats; CoVs from the BtKY18-like 
cluster were detected in Chaerophon spp., Eidolon helvum, 
and R. aegyptiacus bats; and CoVs from the BtHKU9-like 
cluster were detected in Hipposidereos commersoni and R. 
aegyptiacus bats. 
Conclusions
These data demonstrate that the CoV diversity in bats 
previously detected in Asia, Europe, and North America 
is also present, possibly to a greater extent, in Africa. The 
extent of this diversity among CoVs may be shown more 
clearly through additional studies in bats, and increased 
demonstration of CoV diversity in bats may require a re-
consideration of how they should be grouped. The frequen-
cy and diversity of CoV detections in bats, now in multiple 
continents, demonstrate that bats are likely an important 
source for introduction into other species globally. Under-
standing the extent and diversity of CoV infection in bats 
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Figure 2. Phylogenetic tree generated using Bayesian 
Markov Chain Monte Carlo analysis implemented in Bayesian 
Evolutionary Analysis Sampling Trees (BEAST; http://beast.
bio.ed.ac.uk) by using a 121-nt fragment of the RdRp gene 1b 
from 39 coronaviruses (CoVs) in bats from Kenya. CoVs from 
this study are shown in boldface; an additional 47 selected 
human and animal coronaviruses from the National Center for 
Biotechnology Information database are included. The Bayesian 
posterior probabilities were given for deeper nodes. CoV groups 
(1 to 3) based on International Committee on Taxonomy of Viruses 
recommendation are indicated. Bat coronaviruses from the 
People’s Republic of China (*), northern Germany (†), and North 
America (‡) are labeled. Scale bar indicates number of nucleotide 
substitutions per site.Coronaviruses in Bats from Kenya
provides a foundation for detecting new disease introduc-
tions that may, like SARS, present a public health threat. 
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